Início › Câncer de Pulmão de Não Pequenas Células › Illinois › Cicero
Ensaios clínicos de Câncer de Pulmão de Não Pequenas Células em Cicero, IL
24 estudos para Câncer de Pulmão de Não Pequenas Células estão buscando participantes em locais em Cicero e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
RecrutandoFase 1/2
- Hope And Healing Cancer Services /ID# 276223, Hinsdale · a 10 mi de distância
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RecrutandoFase 3
- Edward Hines Jr VA Hospital, Hines · a 4 mi de distância
- Advocate Christ Medical Center, Oak Lawn · a 9 mi de distância
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RecrutandoFase 3
- Northwestern Medicine Oak Brook, Oak Brook · a 9 mi de distância
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RecrutandoFase 3
- Hope and Healing Cancer Services, Hinsdale · a 10 mi de distância
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
RecrutandoFase 3
- Advocate Christ Medical Center, Oak Lawn · a 9 mi de distância
- Hope and Healing Cancer Services, Hinsdale · a 10 mi de distância
- Endeavor Health, Elmhurst · a 10 mi de distância
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
RecrutandoFase 2
- Hope and Healing Clinical Research, Hinsdale · a 10 mi de distância
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
RecrutandoFase 3
- Research Site, Hinsdale · a 10 mi de distância
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
RecrutandoFase 3
- Affiliated Oncologists, LLC, Chicago Ridge · a 10 mi de distância
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
RecrutandoFase 3
- Research Site, Hinsdale · a 10 mi de distância
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
RecrutandoFase 2/3
- Loyola University Medical Center, Maywood · a 5 mi de distância
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
RecrutandoFase 3
- Hope and Healing Cancer Services, Hinsdale · a 10 mi de distância
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RecrutandoFase 3
- Affiliated Oncologists, LLC, Chicago Ridge · a 10 mi de distância
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
RecrutandoFase 3
- Research Site, Hinsdale · a 10 mi de distância
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
RecrutandoFase 3
- Research Site, Hinsdale · a 10 mi de distância
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
RecrutandoFase 3
- Northwestern Medicine Oak Brook, Oak Brook · a 9 mi de distância
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
RecrutandoFase 3
- Elmhurst Hospital Nancy Knowles Cancer Center, Elmhurst · a 10 mi de distância
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RecrutandoFase 2
- Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park · a 3 mi de distância
- Edward Hines Jr VA Hospital, Hines · a 4 mi de distância
- Loyola University Medical Center, Maywood · a 5 mi de distância
- e mais 2
MYLUNG Consortium Part 3: Observational Study
RecrutandoEstudo observacional
- Affiliated Oncologists, LLC, Chicago Ridge · a 10 mi de distância
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
RecrutandoFase 2
- Edward Hines Jr VA Hospital, Hines · a 4 mi de distância
- Loyola University Medical Center, Maywood · a 5 mi de distância
- Northwestern Medicine Oak Brook, Oak Brook · a 9 mi de distância
- e mais 3
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RecrutandoFase 2/3
- Loyola University Medical Center, Maywood · a 5 mi de distância
- Northwestern Medicine Oak Brook, Oak Brook · a 9 mi de distância
- Advocate Christ Medical Center, Oak Lawn · a 9 mi de distância
- e mais 2
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RecrutandoFase 2
- Edward Hines Jr VA Hospital, Hines · a 4 mi de distância
- Loyola University Medical Center, Maywood · a 5 mi de distância
- Northwestern Medicine Oak Brook, Oak Brook · a 9 mi de distância
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RecrutandoEstudo observacional
- Advocate Christ Medical Center, Oak Lawn · a 9 mi de distância
- Advocate Outpatient Center - Oak Lawn, Oak Lawn · a 9 mi de distância
- Advocate High Tech Medical Park, Palos Heights · a 12 mi de distância
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Recrutando
- Edward Hines Jr. VA Hospital, Hines, IL, Hines · a 4 mi de distância
GEMINI-NSCLC: NSCLC Biomarker Study
RecrutandoEstudo observacional
- Hope and Healing Cancer Services, Hinsdale · a 10 mi de distância
Ensaios de Câncer de Pulmão de Não Pequenas Células em outras cidades
- Houston, TX145 estudos
- New York City, NY121 estudos
- Arlington, VA104 estudos
- Nashville, TN97 estudos
- Boston, MA90 estudos
- Los Angeles, CA87 estudos
- St. Louis, MO73 estudos
- Chicago, IL61 estudos
- Baltimore, MD60 estudos
- San Antonio, TX59 estudos
- Columbus, OH57 estudos
- Washington, DC55 estudos
Outros estudos em Cicero
- Câncer de Pulmão17 estudos
- Câncer de Próstata14 estudos
- Câncer (todos os tipos)13 estudos
- Câncer de Mama11 estudos
- Leucemia Mieloide Aguda11 estudos
- Câncer Colorretal10 estudos
- Câncer de Bexiga8 estudos
- Melanoma7 estudos
- Doença Cardiovascular7 estudos
- Câncer Metastático7 estudos
- Mieloma Múltiplo6 estudos
- Linfoma de Burkitt6 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.